Works matching IS 14752840 AND DT 2020 AND VI 19

Results: 214
    1
    2

    Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II).

    Published in:
    Cardiovascular Diabetology, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12933-020-01140-2
    By:
    • Maddaloni, Ernesto;
    • D'Onofrio, Luca;
    • Alessandri, Francesco;
    • Mignogna, Carmen;
    • Leto, Gaetano;
    • Pascarella, Giuseppe;
    • Mezzaroma, Ivano;
    • Lichtner, Miriam;
    • Pozzilli, Paolo;
    • Agrò, Felice Eugenio;
    • Rocco, Monica;
    • Pugliese, Francesco;
    • Lenzi, Andrea;
    • Holman, Rury R.;
    • Mastroianni, Claudio Maria;
    • Buzzetti, Raffaella;
    • the CoViDiab Study Group;
    • Ajassa, Camilla;
    • Alban, Rugova;
    • Alessi, Federica
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes.

    Published in:
    Cardiovascular Diabetology, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12933-020-01125-1
    By:
    • Jin, Jing-Lu;
    • Zhang, Hui-Wen;
    • Cao, Ye-Xuan;
    • Liu, Hui-Hui;
    • Hua, Qi;
    • Li, Yan-Fang;
    • Zhang, Yan;
    • Guo, Yuan-Lin;
    • Wu, Na-Qiong;
    • Zhu, Cheng-Gang;
    • Xu, Rui-Xia;
    • Gao, Ying;
    • Li, Xiao-Lin;
    • Cui, Chuan-Jue;
    • Liu, Geng;
    • Sun, Jing;
    • Dong, Qian;
    • Santos, Raul;
    • Li, Jian-Jun
    Publication type:
    Article
    14
    15

    Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial.

    Published in:
    Cardiovascular Diabetology, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12933-020-01131-3
    By:
    • Hansen, Christian Stevns;
    • Lundby-Christiansen, Louise;
    • Tarnow, Lise;
    • Gluud, Christian;
    • Hedetoft, Christoffer;
    • Thorsteinsson, Birger;
    • Hemmingsen, Bianca;
    • Wiinberg, Niels;
    • Sneppen, Simone B.;
    • Lund, Søren S.;
    • Krarup, Thure;
    • Madsbad, Sten;
    • Almdal, Thomas;
    • Carstensen, Bendix;
    • Jørgensen, Marit E.;
    • the CIMT study group;
    • Almdal, T.;
    • Boesgaard, T. W.;
    • Breum, L.;
    • Gade-Rasmussen, B.
    Publication type:
    Article
    16
    17

    Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial.

    Published in:
    Cardiovascular Diabetology, 2020, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12933-020-01127-z
    By:
    • Shimizu, Wataru;
    • Kubota, Yoshiaki;
    • Hoshika, Yu;
    • Mozawa, Kosuke;
    • Tara, Shuhei;
    • Tokita, Yukichi;
    • Yodogawa, Kenji;
    • Iwasaki, Yu-ki;
    • Yamamoto, Takeshi;
    • Takano, Hitoshi;
    • Tsukada, Yayoi;
    • Asai, Kuniya;
    • Miyamoto, Masaaki;
    • Miyauchi, Yasushi;
    • Kodani, Eitaro;
    • Ishikawa, Masahiro;
    • Maruyama, Mitsunori;
    • Ogano, Michio;
    • Tanabe, Jun;
    • EMBODY trial investigators
    Publication type:
    Article
    18
    19

    Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study.

    Published in:
    Cardiovascular Diabetology, 2020, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12933-020-01123-3
    By:
    • Biscetti, Federico;
    • Nardella, Elisabetta;
    • Rando, Maria Margherita;
    • Cecchini, Andrea Leonardo;
    • Bonadia, Nicola;
    • Bruno, Piergiorgio;
    • Angelini, Flavia;
    • Di Stasi, Carmine;
    • Contegiacomo, Andrea;
    • Santoliquido, Angelo;
    • Pitocco, Dario;
    • Landolfi, Raffaele;
    • Flex, Andrea
    Publication type:
    Article
    20
    21
    22
    23
    24

    Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction.

    Published in:
    Cardiovascular Diabetology, 2020, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12933-020-01114-4
    By:
    • Abe, Takahiro;
    • Yokota, Takashi;
    • Fukushima, Arata;
    • Kakutani, Naoya;
    • Katayama, Takashi;
    • Shirakawa, Ryosuke;
    • Maekawa, Satoshi;
    • Nambu, Hideo;
    • Obata, Yoshikuni;
    • Yamanashi, Katsuma;
    • Nakano, Ippei;
    • Takada, Shingo;
    • Yokota, Isao;
    • Okita, Koichi;
    • Kinugawa, Shintaro;
    • Anzai, Toshihisa
    Publication type:
    Article
    25
    26

    Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study.

    Published in:
    Cardiovascular Diabetology, 2020, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12933-020-01122-4
    By:
    • Bourron, Olivier;
    • Phan, Franck;
    • Diallo, Mamadou Hassimiou;
    • Hajage, David;
    • Aubert, Carole-Elodie;
    • Carlier, Aurélie;
    • Salem, Joe-Elie;
    • Funck-Brentano, Christian;
    • Kemel, Salim;
    • Cluzel, Philippe;
    • Redheuil, Alban;
    • Davaine, Jean-Michel;
    • Massy, Ziad;
    • Mentaverri, Romuald;
    • Bonnefont-Rousselot, Dominique;
    • Gillery, Philippe;
    • Jaisson, Stéphane;
    • Vermeer, Cees;
    • Lacorte, Jean-Marc;
    • Bouziri, Nesrine
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Pericardial fat and its influence on cardiac diastolic function.

    Published in:
    Cardiovascular Diabetology, 2020, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12933-020-01097-2
    By:
    • de Wit-Verheggen, Vera H. W.;
    • Altintas, Sibel;
    • Spee, Romy J. M.;
    • Mihl, Casper;
    • van Kuijk, Sander M. J.;
    • Wildberger, Joachim E.;
    • Schrauwen-Hinderling, Vera B.;
    • Kietselaer, Bas L. J. H.;
    • van de Weijer, Tineke
    Publication type:
    Article
    37
    38

    Omega-3 polyunsaturated fatty acid supplementation versus placebo on vascular health, glycaemic control, and metabolic parameters in people with type 1 diabetes: a randomised controlled preliminary trial.

    Published in:
    Cardiovascular Diabetology, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12933-020-01094-5
    By:
    • O'Mahoney, Lauren L.;
    • Dunseath, Gareth;
    • Churm, Rachel;
    • Holmes, Mel;
    • Boesch, Christine;
    • Stavropoulos-Kalinoglou, Antonios;
    • Ajjan, Ramzi A.;
    • Birch, Karen M.;
    • Orsi, Nicolas M.;
    • Mappa, Georgia;
    • Price, Oliver J.;
    • Campbell, Matthew D.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50